Skip to main content
Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences 2/2011

01.03.2011 | Original article

The distribution of atypical epithelium in main-duct type intraductal papillary mucinous neoplasms of the pancreas

verfasst von: Tatsuo Ito, Ryuichiro Doi, Akihiko Yoshizawa, Morito Sakikubo, Kazuyuki Nagai, Atsushi Kida, Masayuki Koizumi, Toshihiko Masui, Yoshiya Kawaguchi, Toshiaki Manabe, Shinji Uemoto

Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Background/Purpose

The purpose of this study was to obtain the fundamental data necessary to discuss the appropriate operative mode for the resection of main-duct type intraductal papillary mucinous neoplasms (mIPMNs) of the pancreas.

Methods

In 23 patients who underwent total pancreatectomy with preoperative and postoperative diagnoses of mIPMN, the imaging studies and clinicopathological data were collected. The whole pancreatic specimen was histologically evaluated, and the distribution of atypical epithelium was mapped on a schema.

Results

Pathological examination of the specimens revealed that 18 patients had carcinoma in the pancreas; 8 patients had invasive lesions and one patient had lymph node metastasis. Specimens from 5 patients did not bear carcinoma lesions but had widespread borderline lesions in the pancreas. The mapping of lesions in the pancreatic specimens revealed that, at least, borderline or higher lesions were present both in the head and distal pancreas in all patients. In the majority of the specimens, lesions from adenoma to carcinoma co-existed on the same slide, and there were normal cell intervals between the malignant lesions.

Conclusion

We conclude that total pancreatectomy should be performed for mIPMN when dilatation of the main duct suggests possible spread of the lesion to the whole pancreas.
Literatur
1.
Zurück zum Zitat Ohhashi K, Murakami Y, Maruyama M, Takekoshi T, Ohta H, Ohhashi I, et al. Four cases of mucous secreting pancreatic cancer. Prog Dig Endosc. 1982;20:348–51. Ohhashi K, Murakami Y, Maruyama M, Takekoshi T, Ohta H, Ohhashi I, et al. Four cases of mucous secreting pancreatic cancer. Prog Dig Endosc. 1982;20:348–51.
2.
Zurück zum Zitat Furukawa T, Takahashi T, Kobari M, Matsuno S. The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mapping. Cancer. 1992;70:1505–13.PubMedCrossRef Furukawa T, Takahashi T, Kobari M, Matsuno S. The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mapping. Cancer. 1992;70:1505–13.PubMedCrossRef
3.
Zurück zum Zitat Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.PubMedCrossRef Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.PubMedCrossRef
4.
Zurück zum Zitat Longnecker D, Adler G, Hruban R, Kloppel G. Intraductal papillary-mucinous neoplasm of the pancreas. Lyon: IARC press; 2000. Longnecker D, Adler G, Hruban R, Kloppel G. Intraductal papillary-mucinous neoplasm of the pancreas. Lyon: IARC press; 2000.
5.
Zurück zum Zitat Japan Pancreas Society. General rules for the study of pancreatic cancer. Tokyo: Kanehara; 2002. Japan Pancreas Society. General rules for the study of pancreatic cancer. Tokyo: Kanehara; 2002.
6.
Zurück zum Zitat Kobari M, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg. 1999;134:1131–6.PubMedCrossRef Kobari M, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg. 1999;134:1131–6.PubMedCrossRef
7.
Zurück zum Zitat Terris B, Ponsot P, Paye F, Hammel P, Sauvanet A, Molas G, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol. 2000;24:1372–7.PubMedCrossRef Terris B, Ponsot P, Paye F, Hammel P, Sauvanet A, Molas G, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol. 2000;24:1372–7.PubMedCrossRef
8.
Zurück zum Zitat Doi R, Fujimoto K, Wada M, Imamura M. Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery. 2002;132:80–5.PubMedCrossRef Doi R, Fujimoto K, Wada M, Imamura M. Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery. 2002;132:80–5.PubMedCrossRef
9.
Zurück zum Zitat Matsumoto T, Aramaki M, Yada K, Hirano S, Himeno Y, Shibata K, et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol. 2003;36:261–5.PubMedCrossRef Matsumoto T, Aramaki M, Yada K, Hirano S, Himeno Y, Shibata K, et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol. 2003;36:261–5.PubMedCrossRef
10.
Zurück zum Zitat Kitagawa Y, Unger T, Taylor S, Kozarek R, Traverso L. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg. 2003;7:12–8.PubMedCrossRef Kitagawa Y, Unger T, Taylor S, Kozarek R, Traverso L. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg. 2003;7:12–8.PubMedCrossRef
11.
Zurück zum Zitat Sugiyama M, Izumisato Y, Abe N, Masaki T, Mori T, Atomi Y. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg. 2003;90:1244–9.PubMedCrossRef Sugiyama M, Izumisato Y, Abe N, Masaki T, Mori T, Atomi Y. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg. 2003;90:1244–9.PubMedCrossRef
12.
Zurück zum Zitat Sohn T, Yeo C, Cameron J, Hruban R, Fukushima N, Campbell K, Lillemoe K. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788–97.PubMedCrossRef Sohn T, Yeo C, Cameron J, Hruban R, Fukushima N, Campbell K, Lillemoe K. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788–97.PubMedCrossRef
13.
Zurück zum Zitat Salvia R, Fernández-del Castillo C, Bassi C, Thayer S, Falconi M, Mantovani W, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678–85.PubMedCrossRef Salvia R, Fernández-del Castillo C, Bassi C, Thayer S, Falconi M, Mantovani W, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678–85.PubMedCrossRef
14.
Zurück zum Zitat Choi B, Kim T, Kim A, Kim K, Park S, Kim P, et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean J Radiol. 2003;4:157–62.PubMedCrossRef Choi B, Kim T, Kim A, Kim K, Park S, Kim P, et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean J Radiol. 2003;4:157–62.PubMedCrossRef
15.
Zurück zum Zitat Kim S, Park K, Lee Y, Lee S, Seo D, Lee S, et al. Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J Hepatobiliary Pancreat Surg. 2008;15:183–8.PubMedCrossRef Kim S, Park K, Lee Y, Lee S, Seo D, Lee S, et al. Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J Hepatobiliary Pancreat Surg. 2008;15:183–8.PubMedCrossRef
16.
Zurück zum Zitat Manfredi R, Graziani R, Motton M, Mantovani W, Baltieri S, Tognolini A, et al. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology. 2009;253:106–15.PubMedCrossRef Manfredi R, Graziani R, Motton M, Mantovani W, Baltieri S, Tognolini A, et al. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology. 2009;253:106–15.PubMedCrossRef
17.
Zurück zum Zitat Chari S, Yadav D, Smyrk T, DiMagno E, Miller L, Raimondo M, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123:1500–7.PubMedCrossRef Chari S, Yadav D, Smyrk T, DiMagno E, Miller L, Raimondo M, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123:1500–7.PubMedCrossRef
18.
Zurück zum Zitat Maire F, Hammel P, Terris B, Paye F, Scoazec J, Cellier C, et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut. 2002;51:717–22.PubMedCrossRef Maire F, Hammel P, Terris B, Paye F, Scoazec J, Cellier C, et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut. 2002;51:717–22.PubMedCrossRef
19.
Zurück zum Zitat Raimondo M, Tachibana I, Urrutia R, Burgart L, DiMagno E. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol. 2002;97:2553–8.PubMedCrossRef Raimondo M, Tachibana I, Urrutia R, Burgart L, DiMagno E. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol. 2002;97:2553–8.PubMedCrossRef
20.
Zurück zum Zitat Wada K, Kozarek R, Traverso L. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg. 2005;189:632–6.PubMedCrossRef Wada K, Kozarek R, Traverso L. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg. 2005;189:632–6.PubMedCrossRef
21.
Zurück zum Zitat Jang J, Kim S, Ahn Y, Yoon Y, Choi M, Lee K, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol. 2005;12:124–32.PubMedCrossRef Jang J, Kim S, Ahn Y, Yoon Y, Choi M, Lee K, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol. 2005;12:124–32.PubMedCrossRef
22.
Zurück zum Zitat Raut C, Cleary K, Staerkel G, Abbruzzese J, Wolff R, Lee J, et al. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol. 2006;13:582–94.PubMedCrossRef Raut C, Cleary K, Staerkel G, Abbruzzese J, Wolff R, Lee J, et al. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol. 2006;13:582–94.PubMedCrossRef
23.
Zurück zum Zitat Schnelldorfer T, Sarr M, Nagorney D, Zhang L, Smyrk T, Qin R, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008;143:639–46.PubMedCrossRef Schnelldorfer T, Sarr M, Nagorney D, Zhang L, Smyrk T, Qin R, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008;143:639–46.PubMedCrossRef
24.
Zurück zum Zitat Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2008;32:243–55.PubMedCrossRef Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2008;32:243–55.PubMedCrossRef
25.
Zurück zum Zitat Stauffer J, Nguyen J, Heckman M, Grewal M, Dougherty M, Gill K, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford). 2009;11:483–92. Stauffer J, Nguyen J, Heckman M, Grewal M, Dougherty M, Gill K, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford). 2009;11:483–92.
26.
Zurück zum Zitat Yang A, Melstrom L, Bentrem D, Ujiki M, Wayne J, Strouch M, et al. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007;142:529–34.PubMedCrossRef Yang A, Melstrom L, Bentrem D, Ujiki M, Wayne J, Strouch M, et al. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience. Surgery. 2007;142:529–34.PubMedCrossRef
Metadaten
Titel
The distribution of atypical epithelium in main-duct type intraductal papillary mucinous neoplasms of the pancreas
verfasst von
Tatsuo Ito
Ryuichiro Doi
Akihiko Yoshizawa
Morito Sakikubo
Kazuyuki Nagai
Atsushi Kida
Masayuki Koizumi
Toshihiko Masui
Yoshiya Kawaguchi
Toshiaki Manabe
Shinji Uemoto
Publikationsdatum
01.03.2011
Verlag
Springer Japan
Erschienen in
Journal of Hepato-Biliary-Pancreatic Sciences / Ausgabe 2/2011
Print ISSN: 1868-6974
Elektronische ISSN: 1868-6982
DOI
https://doi.org/10.1007/s00534-010-0337-6

Weitere Artikel der Ausgabe 2/2011

Journal of Hepato-Biliary-Pancreatic Sciences 2/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.